BioCentury
ARTICLE | Company News

Teva, Lupin deal

August 4, 2014 7:00 AM UTC

Teva granted Lupin rights to market 100 and 200 mg dosage strengths of a generic version of Teva's sleep disorder drug Nuvigil armodafinil 180 days after Actavis plc (NYSE:ACT, Dublin, Ireland) laun...